Birgitta Versluijs

125 Respiratory virus infection pre-HCT and alloimmune-mediated lung syndromes Supplemental data Figure S1. A: Cumulative incidence of BOS according to sex. B: Cumulative incidence of BOS according to positive BAL fluid RV results. Figure S2. A: Cumulative incidence of IPS according to positive BAL fluid RV results. B: Cumulative incidence of IPS according to diagnosis. Inborn error of metabolism 23% (±8) PID 10% (±5) Malignancy 5% (±2) Bone marrow failure 0% (±0) 7 A Days after HCT Days after HCT p=0.06 Female 12% (±5) Male 4% (±2) B RV positive 2% (±2) RV negative 12% (±4) A B Days after HCT Days after HCT p=0.002 p=0.02 RV positive 17% (±5) RV negative 3% (±2)